Rajnath Singh to release first batch of DRDO's anti-COVID oral drug 2DG today
Published
Developed by DRDO's INMAS, in collaboration with Dr Reddy's Laboratories in Hyderabad, the 2DG drug is an anti-Covid therapeutic application.
Full ArticlePublished
Developed by DRDO's INMAS, in collaboration with Dr Reddy's Laboratories in Hyderabad, the 2DG drug is an anti-Covid therapeutic application.
Full Article